Ube to close caprolactam facility in Japan

摘要

Ube Industries says it will cease production of caprolactam at Sakai, Japan, by March 2014. Growth in demand for caprolactam has weakened with the economic downturn, and Ube's market share has been heavily eroded by the entry of new manufacturers and expansion by existing manufacturers, mainly in China, the company says. Prices of benzene feedstock and auxiliary materials have risen too.